- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/665 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
Patent holdings for IPC class C07K 14/665
Total number of patents in this class: 62
10-year publication summary
3
|
6
|
5
|
2
|
3
|
4
|
1
|
1
|
4
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Ipsen Pharma S.A.S. | 375 |
6 |
Endevica bio, Inc. | 22 |
6 |
Charite - Universitatsmedizin Berlin | 384 |
4 |
Medizinische Universitat Wien | 197 |
3 |
Preveceutical Medical Inc. | 26 |
3 |
Provincial Health Services Authority | 186 |
3 |
Centre National de La Recherche Scientifique | 10564 |
2 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2188 |
2 |
Charite - Universitaetsmedizin Berlin | 23 |
2 |
National Research Council of Canada | 1550 |
2 |
Trustees of Tufts College | 888 |
2 |
Tufts Medical Center, Inc. | 223 |
2 |
Allergan, Inc. | 2337 |
1 |
The Administrators of the Tulane Educational Fund | 397 |
1 |
Bar-Ilan University | 429 |
1 |
Cytogel Pharma, LLC | 22 |
1 |
Embrapa-empresa Brasileira de Pesquisa Agropecuaria | 33 |
1 |
Fundação Universidade de Brasília - FUB - UNB | 10 |
1 |
Instytut Farmakologii Polskiej Akademii Nauk | 9 |
1 |
Ipsen Bioinnovation Limited | 40 |
1 |
Other owners | 17 |